Ref: MEC 254
Galapagos has engaged a significant effort aiming at acquiring external assets that fit within the company’s scientific strategy. The “Scientific Evaluation Lead” will be responsible for identifying and assessing external project opportunities, mainly in the fields of auto-immune diseases and fibrosis. The position will be involved in sourcing external assets, organizing and leading various due diligence processes up to the presentation of selected assets to the internal evaluation board of Galapagos. This is a key position for the future success of the organisation. The Lead will report the Therapeutic Area head and operate in close relationship with diverse members of the Therapeutic Area group as well as with the Business Development department.
Both small and large molecule asset types will be investigated at diverse stages of drug discovery, ranging from H2L to clinical. Therefore, a strong scientific background, a critical mindset as well as a broad experience in drug discovery (pharmacology, pharmacokinetics) are expected for this position. Besides scientific qualities, the Lead will need strong networking capabilities, establishing key contacts with external parties looking for partnering/outlicensing opportunities. A clear view on competitive environments is part of the knowledge to be gathered to correctly interpret the potential impact of a certain asset. Therefore, the Lead will also track progress and strategies of competitors within key therapeutic areas, through the interaction with internal experts, KOLs, congresses and literature. Having an overall sense on financial projections, exit analyses could be useful.
The ideal candidate will have: